| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.9M | +2.2% | +7.7% |
| Cost of Revenue | $996K | +7.6% | +10.2% |
| Gross Profit | $1.9M | -0.4% | +6.5% |
| R&D Expense | $161K | +16.9% | +67.0% |
| SG&A Expense | $1.7M | -27.2% | -2.5% |
| Operating Income | -$1.7M | +18.6% | -8.6% |
| Pre-tax Income | -$1.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $8K | -94.5% | -92.9% |
| Inventory | $1.0M | +32.8% | +28.1% |
| Current Assets | $13.5M | -6.7% | +93.0% |
| Total Assets | $22.4M | -4.6% | +39.5% |
| Current Liabilities | $2.4M | +25.3% | +28.1% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.4M | — | — |
| Capital Expenditures | $22K | — | — |
| Investing Cash Flow | -$8.6M | — | — |
| Financing Cash Flow | $12.3M | — | — |
| Free Cash Flow | -$3.4M | — | — |
| +20.8% |
| -7.0% |
| Net Income | -$1.6M | +20.8% | -7.0% |
| EPS (Basic) | -$2.21 | — | -1005.0% |
| EPS (Diluted) | -$2.21 | — | -1005.0% |
| $2.7M |
| +21.5% |
| +45.3% |
| Stockholders' Equity | $17.8M | -8.1% | +44.4% |